Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Passage BIO, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- −6 vs. Q1 2024
- Shares held
- 40.3M
- −25.6K (−0.1%) vs. Q1 2024
- Total value
- $32.0M
- −$22.4M (−41.2%) vs. Q1 2024
- New holders
- 3
- 8 more added
- Sold out
- 9
- 11 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $13.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.0M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 4 | $4 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 47 | $37 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 60 | $48 | 0.00% | +60 | New |
| LRI Investments, LLC | 225 | $179 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 273 | $217 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 367 | $291 | 0.00% | +366+36,600.0% | Added |
| Global Retirement Partners, LLC | 400 | $318 | 0.00% | +400 | New |
| Rhumbline Advisers | 783 | $621 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 783 | $622 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,146 | $910 | 0.00% | +1,146 | New |
| Royal Bank of Canada | 693 | $1.00K | 0.00% | +193+38.6% | Added |
| Barclays PLC | 13,153 | $10.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 13,203 | $10.5K | 0.00% | +13,169+38,732.4% | Added |
| Morgan Stanley | 13,442 | $10.7K | 0.00% | −395−2.9% | Reduced |
| XTX Topco Ltd | 17,039 | $13.5K | 0.00% | −25,924−60.3% | Reduced |
| FMR LLC | 21,054 | $16.7K | 0.00% | −16−0.1% | Reduced |
| HighTower Advisors, LLC | 21,512 | $17.0K | 0.00% | −251−1.2% | Reduced |
| Cresset Asset Management, LLC | 23,725 | $18.8K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 27,233 | $21.6K | 0.00% | +279+1.0% | Added |
| DLK Investment Management, LLC | 64,000 | $50.8K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 64,512 | $51.2K | 0.00% | −19,755−23.4% | Reduced |
| Marquette Asset Management, LLC | 85,500 | $67.9K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 103,854 | $82.5K | 0.00% | −97,299−48.4% | Reduced |
| State Street Corp | 123,873 | $98.4K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 142,807 | $113.4K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 158,261 | $125.7K | 0.00% | −63,291−28.6% | Reduced |
| Fiduciary Trust Co | 215,000 | $170.8K | 0.00% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 264,266 | $209.9K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 431,110 | $342.5K | 0.00% | +46,832+12.2% | Added |
| Acuitas Investments, LLC | 471,812 | $374.7K | 0.20% | +2,506+0.5% | Added |
| Bridgeway Capital Management, LLC | 556,142 | $441.7K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 750,926 | $596.4K | 0.00% | −114,813−13.3% | Reduced |
| BlackRock Inc. | 817,529 | $649.3K | 0.00% | −105,018−11.4% | Reduced |
| Acadian Asset Management LLC | 961,271 | $762.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,125,574 | $893.9K | 0.00% | −79,950−6.6% | Reduced |
| Tang Capital Management LLC | 1,500,000 | $1.19M | 0.12% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,071,538 | $1.65M | 0.00% | 00.0% | Unchanged |
| Erste Asset Management GmbH | 2,455,800 | $1.96M | 0.03% | 00.0% | Unchanged |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1.98M | 2.41% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 4,026,417 | $3.20M | 4.14% | −933,352−18.8% | Reduced |
| Lynx1 Capital Management LP | 5,057,629 | $4.02M | 1.45% | +211,758+4.4% | Added |
| Vestal Point Capital, LP | 6,052,000 | $4.81M | 0.36% | +1,552,000+34.5% | Added |
| OrbiMed Advisors LLC | 10,124,576 | $8.04M | 0.17% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −209,600−100.0% | Sold out |
| Pale Fire Capital SE | 0 | $0 | 0.00% | −141,435−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,425−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −21,990−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,290−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −3,969−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −309−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −217−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −10−100.0% | Sold out |